Celltrion Healthcare Co., Ltd.

KOSDAQ:A091990 Stock Report

Market Cap: ₩11.9t

Celltrion Healthcare Past Earnings Performance

Past criteria checks 2/6

Celltrion Healthcare has been growing earnings at an average annual rate of 17.4%, while the Healthcare industry saw earnings growing at 16.5% annually. Revenues have been growing at an average rate of 19.2% per year. Celltrion Healthcare's return on equity is 2.1%, and it has net margins of 1.9%.

Key information

17.4%

Earnings growth rate

17.4%

EPS growth rate

Healthcare Industry Growth34.2%
Revenue growth rate19.2%
Return on equity2.1%
Net Margin1.9%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Celltrion Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A091990 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 232,218,02343,133391,90127,636
30 Jun 232,066,847135,951368,37225,918
31 Mar 232,060,053157,644328,42317,367
31 Dec 221,972,188147,178291,72217,750
30 Sep 222,036,930237,067252,14713,519
30 Jun 221,949,646140,048222,28718,709
31 Mar 221,863,891164,644203,17724,428
31 Dec 211,804,486152,567192,81429,227
30 Sep 211,585,653167,523169,94429,755
30 Jun 211,639,954213,010163,15031,618
31 Mar 211,626,987195,722153,70433,177
31 Dec 201,627,597240,407144,89329,733
30 Sep 201,554,163249,216140,99928,353
30 Jun 201,372,783173,262126,49424,626
31 Mar 201,237,266135,315117,09920,011
31 Dec 191,100,87864,962107,40916,684
30 Sep 19976,014-42,02393,44914,486
30 Jun 19906,649-45,78289,39514,479
31 Mar 19805,635-43,27886,14713,953
31 Dec 18713,48711,38679,25813,505
30 Sep 18989,193175,70773,93314,263
30 Jun 18945,767178,49969,50713,608
31 Mar 18991,440238,44760,64412,795
31 Dec 17921,500165,68457,74412,036
30 Sep 17872,771136,60451,2318,277
30 Jun 17876,929167,56244,7376,845
31 Mar 17741,59094,03739,5216,785
31 Dec 16756,437123,50336,0287,130
31 Dec 15376,033-6,74031,8674,120
31 Dec 14166,54910,13341,4132,165

Quality Earnings: A091990 has high quality earnings.

Growing Profit Margin: A091990's current net profit margins (1.9%) are lower than last year (11.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A091990's earnings have grown by 17.4% per year over the past 5 years.

Accelerating Growth: A091990's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A091990 had negative earnings growth (-81.8%) over the past year, making it difficult to compare to the Healthcare industry average (-3.8%).

Return on Equity

High ROE: A091990's Return on Equity (2.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/12 13:09
End of Day Share Price 2024/01/12 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Celltrion Healthcare Co., Ltd. is covered by 29 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Girish BakhruBofA Global Research
Hyung Soo KimCape Investment & Securities Co., Ltd.
Sunghwan KimCredit Suisse